Navigation Links
Guidelines Issued for New Blood Thinner Brilinta
Date:7/16/2012

MONDAY, July 16 (HealthDay News) -- The new blood-thinning drug Brilinta should be considered along with older drugs to treat patients with unstable angina, according to updated guidelines.

Unstable angina occurs when a partially blocked coronary artery deprives the heart of blood and oxygen. The updated guidelines were issued jointly by the American Heart Association Task Force on Practice Guidelines and the American College of Cardiology Foundation.

"We have put it on equal footing with two other [blood-thinning] medications: clopidogrel (Plavix) and prasugrel (Effient)," lead author Dr. Hani Jneid, assistant professor of medicine and director of interventional cardiology research at Baylor College of Medicine in Houston, said in an American Heart Association news release.

The new guidelines state that Brilinta (ticagrelor), which was approved by the U.S. Food and Drug Administration in 2011, should also be considered to treat a type of heart attack known as non-ST segment elevation myocardial infarction, also known as NSTEMI.

"These conditions are very common and carry a high risk of death and recurrent heart attacks," said Jneid, who also is an interventional cardiologist at the Michael E. DeBakey VA Medical Center in Houston. "The [American Heart Association] and [American College of Cardiology Foundation] constantly update their guidelines so physicians can provide patients with the most appropriate, aggressive therapy with the goal of improving health and survival."

Although all patients with these conditions should still be given aspirin as soon as they are hospitalized, the updated guidelines outlined the following new recommendations:

  • Brilinta or Plavix may be given to patients receiving medical therapy (e.g. aspirin) or having an artery-opening procedure. Patients unable to take aspirin may be given Effient for artery-opening procedures because research on this drug is focused on these patients.
  • Patients undergoing invasive procedures should be given aspirin along with blood-thinning medication.
  • Patients undergoing only treatment with medication should receive aspirin indefinitely and be given Brilinta or Plavix for at least 12 months.

The guidelines' authors added that doctors and hospitals should participate in a quality-of-care data registry to help track and measure outcomes, complications and adherence to evidence-based recommendations.

"While this focused update of the guidelines provides important guidance to clinicians, our recommendations are not substitutes for a physician's own clinical judgments and the tailoring of therapy based on individual variability and a patient's presentation and clinical diagnosis," Jneid said in the news release.

The new guidelines were published July 16 in Circulation: Journal of the American Heart Association and the Journal of the American College of Cardiology.

More information

The U.S. National Library of Medicine has more about unstable angina.

-- Mary Elizabeth Dallas

SOURCE: American Heart Association, news release, July 16, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
2. Diabetes Groups Issue New Guidelines on Blood Sugar
3. Guidelines say diet, exercise, weight control improve odds after cancer diagnosis
4. New guidelines deliver concise messages for implementing cardiovascular prevention
5. New Guidelines Issued for Severe Lupus
6. U.S. Task Force Issues Blood Pressure Guidelines
7. British experts update addiction treatment guidelines
8. New prostate cancer screening guidelines face a tough sell, study suggests
9. The REMARK checklist explained: How to use guidelines on reporting tumor marker prognostic studies
10. Mayo Clinic, youth mental health experts, publish new guidelines to treat childhood aggression
11. Penn and Cornell researchers spearhead the development of new guidelines for veterinary CPR
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Guidelines Issued for New Blood Thinner Brilinta
(Date:7/24/2017)... Lewisville, TX (PRWEB) , ... July 24, 2017 ... ... grants under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State ... State of California Department of Health Care Services, will facilitate the development of ...
(Date:7/24/2017)... ... 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, announced ... and divided between two full-time university students enrolled in U.S. or Canadian accredited ... apply for the scholarship, students are asked to submit an essay between 750 ...
(Date:7/24/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... to expand its solution to help government contractors more quickly and cost-effectively comply ... to address the authentication requirements within NIST SP800-171, but no matter how you ...
(Date:7/24/2017)... ... ... people are taking more steps to protect themselves from sunburn, half of all adults and ... the past year. It’s common and people have been dealing with them since the dawn ... conscientious of the risks that accompany sunburns. , The team at AloeVera.com , a ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... August 13-17 in National Harbor, MD. This year's theme focuses on the new ... principal benchmarks for quality and integrity in testing and calibration will be changed. ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
(Date:7/5/2017)... England , July 5, 2017 Wolfmet ... perfect answer as physics and manufacturing combine to progress molecular ... thyroid, existing SPECT systems are unable to accurately quantify the ... only limited information regarding the success of this radiotherapy treatment ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
Breaking Medicine Technology: